Ketamine and Postoperative Depressive Symptom-PASSION
Primary Purpose
Ketamine; Depressive Symptom; Neurosurgery; Perioperative Period
Status
Completed
Phase
Phase 2
Locations
China
Study Type
Interventional
Intervention
Ketamine
Normal saline
Sponsored by

About this trial
This is an interventional treatment trial for Ketamine; Depressive Symptom; Neurosurgery; Perioperative Period
Eligibility Criteria
Inclusion Criteria:
- Brain tumor located supratentorial area and need to receive elective craniotomy;
- Moderate to severe depressive symptom measured by the qualified psychiatric doctors.
- Ages between 18 and 65 years old.
- American Society of Anesthesiologists physical status I-III
Exclusion Criteria:
- History of epilepsy;
- Major depression disorder patients undergoing antidepressive therapy within 2 weeks; 3 Psychiatric illness; 4 Drug abuse; 5 History of allergy to the research drug; 6 Tumor located in the Wernick area, Broca area or the frontal pole; 7 Hyperthyroidism; 8 Patients can not cooperate with investigators on psychiatric assessments; 9 Pregnant or breast-feeding woman; 10 refuse to sign inform consent.
Sites / Locations
- Beijing TianTan Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Placebo Comparator
Arm Label
ketamine group
normal saline group
Arm Description
Outcomes
Primary Outcome Measures
Response rate
≥50% reduction in MADRS scores from baseline value.The MADRS is a 10-item tool, with scores ranging from 0 to 60, and determining the severity of depression.
Secondary Outcome Measures
The remission rate
The remission rate is defined as the absolute value of MADRS no more than 10.
Anxiety symptom
The anxious symptom is defined as HADS score no less than 11.
Postoperative delirium
Postoperative delirium will be assessed by the Confusion Assessment Method for the Intensive Care Unit Scale (CAM-ICU) at 2 hours and 1 day after surgery.
Severe pain
The incidence of severe pain within first postoperative three days, which is defined as mean and peak numerical rating scale (NRS) are higher than 5.
Postoperative 30-day quality of life reported by KPS
The quality of life will be evaluated by Karnofsky performance status (KPS) at postoperative 30 days.
Psychiatric outcomes and complications
Postoperative complications include psychiatric symptoms evaluated by Brief Psychiatric Rating Scale (BPRS), manic symptoms assessed through the 11-item Young Mania Rating Scale (YMRS), and dissociative symptoms measured by the Clinician Administered Dissociative States Scale (CADSS). Moreover, postoperative complications also include aphasia, epilepsy, hemorrhage.
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT03086148
Brief Title
Ketamine and Postoperative Depressive Symptom-PASSION
Official Title
Effect of Low-dose Ketamine on Postoperative Depressive Symptom in Patients Undergoing Intracranial Tumor Resection (PASSION)
Study Type
Interventional
2. Study Status
Record Verification Date
July 2020
Overall Recruitment Status
Completed
Study Start Date
July 5, 2017 (Actual)
Primary Completion Date
August 24, 2018 (Actual)
Study Completion Date
November 20, 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Beijing Tiantan Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
Perioperative depression symptom (PDS) is one of the common mental comorbidity, and influences the clinical outcomes and prognosis. However, there is no rapid acting treatment to deal with it during the limited hospital stay. This study aims to determine whether ketamine could improve the depressive symptom of peirioperative patients. It will also examine the safety for administrating ketamine as an antidepressant intraoperatively. Meanwhile, it will show if ketamine could improve anxiety, postoperative pain or delirium. This trial also will bring great concerns on patients with perioperative mental health and explore the measures to improve their psycho-related prognosis.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Ketamine; Depressive Symptom; Neurosurgery; Perioperative Period
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2, Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
84 (Actual)
8. Arms, Groups, and Interventions
Arm Title
ketamine group
Arm Type
Experimental
Arm Title
normal saline group
Arm Type
Placebo Comparator
Intervention Type
Drug
Intervention Name(s)
Ketamine
Other Intervention Name(s)
Ketamine hydrochloride
Intervention Description
Ketamine will be administrated intravenously at dural opening, with the total dose of 0.5 mg/kg and continual infusion for 40 minutes.
Intervention Type
Drug
Intervention Name(s)
Normal saline
Intervention Description
Normal saline will be administrated intravenously at dural opening, with the total dose of 0.5 ml/kg and continual infusion for 40 minutes.
Primary Outcome Measure Information:
Title
Response rate
Description
≥50% reduction in MADRS scores from baseline value.The MADRS is a 10-item tool, with scores ranging from 0 to 60, and determining the severity of depression.
Time Frame
Postoperative 3 days
Secondary Outcome Measure Information:
Title
The remission rate
Description
The remission rate is defined as the absolute value of MADRS no more than 10.
Time Frame
Postoperative 3 days and discharge.
Title
Anxiety symptom
Description
The anxious symptom is defined as HADS score no less than 11.
Time Frame
Postoperative 3 days.
Title
Postoperative delirium
Description
Postoperative delirium will be assessed by the Confusion Assessment Method for the Intensive Care Unit Scale (CAM-ICU) at 2 hours and 1 day after surgery.
Time Frame
Postoperative 1 day.
Title
Severe pain
Description
The incidence of severe pain within first postoperative three days, which is defined as mean and peak numerical rating scale (NRS) are higher than 5.
Time Frame
Postoperative 3 days.
Title
Postoperative 30-day quality of life reported by KPS
Description
The quality of life will be evaluated by Karnofsky performance status (KPS) at postoperative 30 days.
Time Frame
Postoperative 30 days
Title
Psychiatric outcomes and complications
Description
Postoperative complications include psychiatric symptoms evaluated by Brief Psychiatric Rating Scale (BPRS), manic symptoms assessed through the 11-item Young Mania Rating Scale (YMRS), and dissociative symptoms measured by the Clinician Administered Dissociative States Scale (CADSS). Moreover, postoperative complications also include aphasia, epilepsy, hemorrhage.
Time Frame
Postoperative 3 days and discharge.
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Brain tumor located supratentorial area and need to receive elective craniotomy;
Moderate to severe depressive symptom measured by the qualified psychiatric doctors.
Ages between 18 and 65 years old.
American Society of Anesthesiologists physical status I-III
Exclusion Criteria:
History of epilepsy;
Major depression disorder patients undergoing antidepressive therapy within 2 weeks; 3 Psychiatric illness; 4 Drug abuse; 5 History of allergy to the research drug; 6 Tumor located in the Wernick area, Broca area or the frontal pole; 7 Hyperthyroidism; 8 Patients can not cooperate with investigators on psychiatric assessments; 9 Pregnant or breast-feeding woman; 10 refuse to sign inform consent.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ruquan Han, M.D., Ph.D
Organizational Affiliation
Department of Anesthesiology, Beijing Tiantan Hospital
Official's Role
Study Chair
Facility Information:
Facility Name
Beijing TianTan Hospital
City
Beijing
ZIP/Postal Code
100070
Country
China
12. IPD Sharing Statement
Citations:
PubMed Identifier
34633992
Citation
Zhou Y, Sun W, Zhang G, Wang A, Lin S, Chan MTV, Peng Y, Wang G, Han R. Ketamine Alleviates Depressive Symptoms in Patients Undergoing Intracranial Tumor Resection: A Randomized Controlled Trial. Anesth Analg. 2021 Dec 1;133(6):1588-1597. doi: 10.1213/ANE.0000000000005752.
Results Reference
derived
PubMed Identifier
30157913
Citation
Zhou Y, Peng Y, Fang J, Sun W, Zhang G, Zhen L, Wang G, Han R. Effect of low-dose ketamine on PerioperAtive depreSsive Symptoms in patients undergoing Intracranial tumOr resectioN (PASSION): study protocol for a randomized controlled trial. Trials. 2018 Aug 29;19(1):463. doi: 10.1186/s13063-018-2831-0.
Results Reference
derived
Learn more about this trial
Ketamine and Postoperative Depressive Symptom-PASSION
We'll reach out to this number within 24 hrs